The DGCI has approved Covaxin manufacturer, Bharat Biotech's Phase-III clinical trials for the intranasal booster dose BBV154 (Nasal covid vaccine) on individuals who...
India's drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to...